KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Finished Goods (2016 - 2018)

Bausch Health Companies' Finished Goods history spans 7 years, with the latest figure at $564.0 million for Q4 2018.

  • For Q4 2018, Finished Goods fell 9.9% year-over-year to $564.0 million; the TTM value through Dec 2018 reached $564.0 million, down 9.9%, while the annual FY2018 figure was $564.0 million, 9.9% down from the prior year.
  • Finished Goods for Q4 2018 was $564.0 million at Bausch Health Companies, down from $584.0 million in the prior quarter.
  • Across five years, Finished Goods topped out at $843.0 million in Q2 2015 and bottomed at $564.0 million in Q4 2018.
  • The 5-year median for Finished Goods is $618.0 million (2018), against an average of $658.1 million.
  • The largest annual shift saw Finished Goods surged 34.96% in 2015 before it fell 16.56% in 2016.
  • A 5-year view of Finished Goods shows it stood at $603.9 million in 2014, then soared by 34.96% to $815.0 million in 2015, then fell by 16.56% to $680.0 million in 2016, then dropped by 7.94% to $626.0 million in 2017, then dropped by 9.9% to $564.0 million in 2018.
  • Per Business Quant, the three most recent readings for BHC's Finished Goods are $564.0 million (Q4 2018), $584.0 million (Q3 2018), and $589.0 million (Q2 2018).